United States Human Immunoglobulin Market was valued at USD 5.5 Billion in 2022 and is projected to reach USD 8.0 Billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030.
The US Human Immunoglobulin market has witnessed substantial growth in recent years, driven by increasing demand from various industries. Immunoglobulins are vital proteins used in the treatment of immune deficiencies, autoimmune diseases, and certain infections. They are sourced from human blood plasma and used in a variety of medical applications. The rising awareness of immunoglobulin therapies' effectiveness and the growing number of chronic diseases have intensified the need for human immunoglobulin in the market.
One of the major types of human immunoglobulin is intravenous immunoglobulin (IVIG), which is used to treat conditions like chronic inflammatory demyelinating polyneuropathy (CIDP) and idiopathic thrombocytopenic purpura (ITP). Subcutaneous immunoglobulin (SCIG) is also gaining popularity due to its ease of administration and fewer side effects. This product is administered directly under the skin, which allows for home therapy and reduces the frequency of hospital visits. The need for both these immunoglobulin types is increasing, spurred by the rise in autoimmune diseases and infections like hepatitis, HIV, and respiratory diseases.
The US market sees substantial demand from the healthcare industry, particularly from hospitals and clinics. These institutions require human immunoglobulin to treat a growing patient base. The pharmaceutical and biotechnology industries are also primary consumers of immunoglobulin, using it for the development of therapeutic products and vaccines. In addition to the healthcare sector, industries like research and diagnostics also require immunoglobulins for creating test kits and further studying disease mechanisms.
Given the increasing demand, manufacturers in the US are scaling up production capacity to meet market needs. The need for continuous improvement in immunoglobulin therapies and delivery methods has become a priority for researchers. Emerging markets and advancements in biotechnology are expected to propel the market further. Additionally, the adoption of human immunoglobulin therapies is becoming more widespread, especially in regions with high healthcare investments.
The application of human immunoglobulin is not only crucial in healthcare but is also intertwined with various industries focused on patient care and advanced medical research. As the industry grows, so does the requirement for high-quality, effective immunoglobulin to meet the evolving needs of different sectors.
Get an In-Depth Research Analysis of the US Human Immunoglobulin Market Size And Forecast [2025-2032]
Takeda
CSL
Grifols
Octapharma
Biotest
China National Pharmaceutical Group Corporation
CTBB
Hualan Bio
RASS
Shanxi Kangbao Biological Product
Shuanglin Bio Pharma
Sichuan Yuanda Shuyang Pharmaceutical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Human Immunoglobulin Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Human Immunoglobulin Market
Intravenous Immunoglobulin (IVIg)
Subcutaneous Immunoglobulin (SCIg)
Intramuscular Immunoglobulin (IMIg)
Specific Immunoglobulins
Hyperimmune Globulins
Primary Immunodeficiency Disorders
Immunomodulation
Autoimmune Diseases
Neurological Disorders
Acute Infections
Human Plasma-Derived Immunoglobulins
Recombinant Immunoglobulins
Pool-Based Immunoglobulins
Monoclonal Antibodies
Polyclonal Antibodies
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Clinics
Direct Sales
Hospitals
Diagnostic Centers
Research Laboratories
Long-term Care Facilities
Home Healthcare Settings
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Human Immunoglobulin Market Research Analysis
1. Introduction of the US Human Immunoglobulin Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Human Immunoglobulin Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Human Immunoglobulin Market, By Type
6. US Human Immunoglobulin Market, By Application
7. US Human Immunoglobulin Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Human Immunoglobulin Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/